We are proud to be named a finalist in three categories at the European Lifestars Awards 2026 🌟🔬 A sincere thank you to the LifeStars Awards committee for this recognition, and to the entire AlzeCure team for their commitment and dedication 💫👏💙✨

Thank you, Redeye, for having us at Neurology Day! 📽️You can watch the presentation via the link below. Martin's presentation begins at 2:00:57: redeye.se/events/1145293/red… #AlzeCure #Neurology #AlzheimersDisease #PainResearch #PainManagement #Redeye

📸 What an inspiring few days in Yokohama! ✨ Grateful to once again be part of BioJapan and for the valuable discussions and new connections! If you haven't already, take a look at this BioStock article: 🔗biostock.se/2026/10/report-f… Thank you, BioJapan. Until next time!

Greeting & Congratulations from Nasdaq on our major deals. Thank you for the recognition, collaboration and support! ⭐ The USD 3.2B in deals refers to AlzeCure Pharma's agreements with Eli Lilly and QuantumCell this summer for our Alzheimer's assets Alzstatin and NeuroRestore!

Time & Place: 18:00 CEST Aulan, Medborgarskolan, Hagagatan 23 A, Stockholm, Sweden The presentation is in Swedish. Information and registration are available on Aktiespararna’s website: aktiespararna.se/aktiviteter… Presentation will be found on our website: alzecurepharma.se/en/present…

Onsdagen den 14 oktober 2026 kl. 18.00 Aulan, Medborgarskolan, Hagagatan 23 A, Stockholm Presentationen hålls på svenska. Mer information och anmälan finns på Aktiespararnas hemsida: aktiespararna.se/aktiviteter… Presentationen finnas på AlzeCures hemsida: alzecurepharma.se/sv/present…

Currently attending Bio Japan 2026 - Oct. 7-9, 2026 in Yokohama Let’s meet up if you are interested to discuss our above projects, and learn more at alzecurepharma.com app.meltwater.com/engage/pub…

Neurology Day is Redeye's annual event on drug development in neurology and brain diseases 🤝🌟 Presentation time: 11:15 CEST, October 15, 2026 Watch the livestream via: redeye.se/events/1145293/red… & found afterwards at: redeye.se/company/alzecure-p… alzecurepharma.se/en/present…

Neurology Day är Redeyes årliga event om läkemedelsutveckling inom neurologi och hjärnsjukdomar 🔬✨ Presentationstid: Kl 11:15 den 15 oktober 2026 Presentationen livesänds och kan följas via: redeye.se/events/1145293/red… i efterhand: alzecurepharma.se/sv/present… redeye.se/company/alzecure-p…

Spelet bakom uppstickarens miljardavtal: ”Givande och tagande” Från Dagens Industri ” I somras säkrade Alzecure Pharma, med endast tolv anställda, två av de största licensaffärerna i svensk biotechhistoria. di.se/nyheter/spelet-bakom-u… #alzecure #elililly #quantumcell

Some highlights from Swiss Nordic Bio this week. ✨🚀 📸 Pictured is our CEO, Martin Jönsson, sharing insights and meeting with pharmaceutical companies, investors, potential partners, and colleagues. Full interview here: biotechtv.com/post/alzecure-…

While attending Swiss Nordic Bio in Zürich, our CEO Martin Jönsson spoke with BioTechTV about AlzeCure's latest progress, our partnerships with Eli Lilly and QuantumCell, and the road ahead. 🎥 Watch the full interview here: biotechtv.com/post/alzecure-…

We’re excited to have our CEO, Martin Jönsson, participating in Swiss Nordic Bio today. Fortunately, the event is being broadcast online. To find out more about today’s broadcast, visit BiotechTV’s website or social media channels. biotechtv.com/

Attending Bio Japan 2026 (Oct 7-9, Yokohama)! AlzeCure Pharma looks forward to meeting pharma companies, investors and partners to discuss our post-out-licensing focus: ACD137 for osteoarthritis and ACD440 for neuropathic pain. Let’s connect!

💜 As Alzheimer's Awareness Month comes to an end, we want to thank everyone who helped raise awareness and support the Alzheimer's community. Together, we move forward with hope. 🧠💜 Visit our website, Linkedin, Instagram, and Youtube channel for more detailed updates!

Seminarium med AlzeCure, BioArctic linkedin.com/organization/59… & DNB Carnegie linkedin.com/organization/10… Stort tack till Hammarskiöld linkedin.com/organization/82… för att ni bjöd in oss till dagens mycket intressanta seminarium och paneldiskussion om Licensiering som strategi.

Presenting at Swiss Nordic Bio October 1st in Zürich, Switzerland 🧠✨ Hope to seeing you there together with partners, pharma companies and investors! More on Swiss Nordic Bio: swissnordicbio.com eur04.safelinks.protection.o…

In this Finwire presentation, AlzeCure CEO Martin Jönsson shares insights into the company's collaborations with Eli Lilly and QuantumCell, ongoing developments, and the vision driving AlzeCure forward. 🎬 Watch now: youtube.com/watch?v=phWLpQaY… 🔔 Subscribe to our YouTube channel!

Today is World Alzheimer's Day💜 Every memory matters. Every patient matters. Every step forward in research brings us closer to a better future. Proud to advance innovative Alzheimer's programs including NeuroRestore® (ACD856) and Alzstatin® (ACD680)🧠 alzecurepharma.se/en/project…

Vi träffade Ylva Nicolae Santesson efter presentationen hos Aktiespararna där vår vd Martin Jönsson talade om AlzeCures vårt bolags ingångna avtal och aktiviteter med Eli Lilly och QuantumCell, samt om AlzeCures målsättningar framöver. Presentationen här: youtube.com/watch?v=VRS3kMc1…